154 related articles for article (PubMed ID: 139066)
1. [Neuraminergic conception of extrapyramidal syndromology].
Levin SL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(2):293-9. PubMed ID: 139066
[No Abstract] [Full Text] [Related]
2. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
Marsden CD
Mod Trends Neurol; 1975; 6():141-66. PubMed ID: 127927
[No Abstract] [Full Text] [Related]
3. Neurochemical anatomy of movement disorders.
Young AB; Penney JB
Neurol Clin; 1984 Aug; 2(3):417-33. PubMed ID: 6152481
[TBL] [Abstract][Full Text] [Related]
4. [Abnormal neurotransmission in neurological diseases (author's transl)].
Toru M
Tanpakushitsu Kakusan Koso; 1979; 24(2):150-9. PubMed ID: 35816
[No Abstract] [Full Text] [Related]
5. Mapping neuronal activity of the basal ganglia in experimental models of Parkinson's disease: contributions of the [14C]2-deoxyglucose method.
Orzi F; Fornai F; Blandini F
Funct Neurol; 2000; 15(4):269-76. PubMed ID: 11213530
[No Abstract] [Full Text] [Related]
6. [Physiology and pharmacology of extrapyramidal tract].
Yoshida M; Mizuno Y
Nihon Rinsho; 1975 Oct; 33(10):2964-77. PubMed ID: 128646
[No Abstract] [Full Text] [Related]
7. [The role of dopamine in the physiology and pathology of the basal ganglia].
Arushanian EB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
[No Abstract] [Full Text] [Related]
8. Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine.
Price KS; Farley IJ; Hornykiewicz O
Adv Biochem Psychopharmacol; 1978; 19():293-300. PubMed ID: 696462
[No Abstract] [Full Text] [Related]
9. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
Bernheimer H; Birkmayer W; Hornykiewicz O; Jellinger K; Seitelberger F
J Neurol Sci; 1973 Dec; 20(4):415-55. PubMed ID: 4272516
[No Abstract] [Full Text] [Related]
10. The striopallidal system: Its implication in motor disorders.
Poirier LJ; Parent A; Roberge AG
Pathobiol Annu; 1975; 5():339-67. PubMed ID: 812038
[No Abstract] [Full Text] [Related]
11. Amine precursors in neurologic disorders and the psychoses.
Klawans H
Res Publ Assoc Res Nerv Ment Dis; 1975; 54():259-76. PubMed ID: 130667
[No Abstract] [Full Text] [Related]
12. Dopamine and extrapyramidal motor function and dysfunction.
Hornykiewicz O
Res Publ Assoc Res Nerv Ment Dis; 1972; 50():390-415. PubMed ID: 4561070
[No Abstract] [Full Text] [Related]
13. Nervous mechanisms involved in experimentally induced extrapyramidal disturbances.
Poirier LJ
Confin Neurol; 1974; 36(4-6):223-36. PubMed ID: 4218801
[No Abstract] [Full Text] [Related]
14. [Nigrostriatal system as a source of torsion extrapyramidal disorders (review)].
Arushanian EB; Dutov AA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):930-8. PubMed ID: 6774537
[No Abstract] [Full Text] [Related]
15. Nucleus ruber and L-dopa psychosis: biochemical post-mortem findings.
Birkmayer W; Danielczyk W; Neumayer E; Riederer P
J Neural Transm; 1974; 35(2):93-116. PubMed ID: 4844103
[No Abstract] [Full Text] [Related]
16. Dopaminergic infllence in the basal ganglia: evidence for striatonigral feedback regulation.
Bunney BS; Aghajanian GK
Res Publ Assoc Res Nerv Ment Dis; 1976; 55():249-67. PubMed ID: 826996
[No Abstract] [Full Text] [Related]
17. [Dopaminergic conception of Parkinsonism and its treatment with L-DOPA].
Levin SL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(9):1418-26. PubMed ID: 4349303
[No Abstract] [Full Text] [Related]
18. Neurohumoral interactions and basal ganglia function and dysfunction.
Hornykiewicz O
Res Publ Assoc Res Nerv Ment Dis; 1976; 55():269-80. PubMed ID: 12547
[No Abstract] [Full Text] [Related]
19. Parkinson's disease: from brain homogenate to treatment.
Hornykiewicz O
Fed Proc; 1973 Feb; 32(2):183-90. PubMed ID: 4143953
[No Abstract] [Full Text] [Related]
20. The pharmacology of tardive dyskinesias.
Klawans HL
Am J Psychiatry; 1973 Jan; 130(1):82-6. PubMed ID: 4264755
[No Abstract] [Full Text] [Related]
[Next] [New Search]
